Benzinga | Dec 15, 2021 08:34AM EST

Quotient Offers Update On MosaiQ Exapnded Immunohematology Microarray CE Marking Progress: Received Feedback From European Notified Body, Was Pleased With Feedback, Sees Response Submission In 'Next Couple Weeks'

* Received feedback from the European notified body after review of Expanded IH submission

* Pleased with feedback and expect to submit a response to the questions in the next couple of weeks

* Continue to expect approval in Q1 CY 2022

JERSEY, Channel Islands, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the company received feedback from the European notified body on the Expanded Immunohematology (IH) submission. The Company is pleased with the feedback and expects to submit a response to the questions in the next couple of weeks.

"I'm very pleased with the recent news and thankful for progress the team has made with this submission. I'm looking forward to executing on our commercialization in the first quarter of next year," said Manuel O. M?ndez, Chief Executive Officer of Quotient.